Business · 31/10/2007
FDA Releases Guidance on HIV Resistance Testing in Antiretroviral Drug Development
The Food and Drug Administration (FDA) has released a guidance document to help pharmaceutical companies develop new treatments for HIV infection, focusing on the role of HIV resistance testing in the drug development process.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →